Candriam S.C.A. Bristol Myers Squibb CO Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Candriam S.C.A. holds 811,645 shares of BMY stock, worth $46.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

811,645

Previous 692,205 17.26%

Holding current value

$46.9 Million

Previous $28.7 Million 46.11%

% of portfolio

0.25%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $4.74 Million - $6.18 Million	119,440 Added 17.26%	811,645 $42 Million
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $1.53 Million - $2.01 Million	-37,921 Reduced 5.19%	692,205 $28.7 Million
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $6.31 Million - $7.15 Million	131,449 Added 21.96%	730,126 $39.6 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $9.04 Million - $10.8 Million	186,370 Added 45.2%	598,677 $30.7 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $6.23 Million - $6.96 Million	-107,549 Reduced 20.69%	412,307 $23.9 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $23.4 Million - $25.9 Million	-366,724 Reduced 41.36%	519,856 $33.2 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $7.95 Million - $9.01 Million	120,926 Added 15.79%	886,580 $61.4 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $22.2 Million - $26.3 Million	324,543 Added 73.57%	765,654 $55.1 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $22,047 - $13 Million	169,594 Added 62.46%	441,111 $31.4 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $490,693 - $540,424	-6,757 Reduced 2.43%	271,517 $20.9 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.86 Million - $2.23 Million	-30,317 Reduced 9.82%	278,274 $20.3 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $3.88 Million - $4.52 Million	-72,359 Reduced 18.99%	308,591 $19.2 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $1.09 Million - $1.28 Million	-18,433 Reduced 4.62%	380,950 $22.5 Million
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $85.8 Million - $93.4 Million	-1,385,399 Reduced 77.62%	399,383 $26.7 Million
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $5,577 - $6,273	-94 Reduced 0.01%	1,784,782 $106 Million
Q4 2020 Jan 22, 2021	BUY	$57.74 - $65.43 $5.22 Million - $5.91 Million	90,350 Added 5.33%	1,784,876 $111 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $10.9 Million - $12.1 Million	189,488 Added 12.59%	1,694,526 $102 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $54.5 Million - $63.7 Million	-993,760 Reduced 39.77%	1,505,038 $88.5 Million
Q1 2020 May 26, 2020	BUY	$46.4 - $67.43 $7,238 - $10,519	156 Added 0.01%	2,498,798 $157 Million
Q4 2019 Jan 21, 2020	SELL	$49.21 - $64.19 $6.02 Million - $7.85 Million	-122,364 Reduced 4.67%	2,498,642 $160,000
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $8.26 Million - $9.79 Million	193,121 Added 7.95%	2,621,006 $133,000
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $20.3 Million - $22.4 Million	454,646 Added 23.04%	2,427,885 $110 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $27.6 Million - $32.9 Million	610,737 Added 44.82%	1,973,239 $94.1 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $16.4 Million - $21.2 Million	335,865 Added 32.72%	1,362,502 $70.8 Million
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $3.76 Million - $4.24 Million	68,092 Added 7.1%	1,026,637 $63.7 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $27.5 Million - $34.2 Million	543,285 Added 130.83%	958,545 $53 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $1.85 Million - $2.13 Million	-30,945 Reduced 6.94%	415,260 $26.3 Million
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $10.6 Million - $11.6 Million	-176,986 Reduced 28.4%	446,205 $27.3 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $34.4 Million - $39.7 Million	623,191	623,191 $39.7 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account